| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1090780650 |
| P356 | DOI | 10.1038/S41598-017-04574-Z |
| P932 | PMC publication ID | 5524914 |
| P698 | PubMed publication ID | 28740200 |
| P50 | author | Lars Kuepfer | Q52350941 |
| Ute Hofmann | Q56433692 | ||
| Donato Teutonico | Q83449830 | ||
| Andreas Schuppert | Q42413919 | ||
| Lars Ole Schwen | Q42530594 | ||
| Ahmed Ghallab | Q43208341 | ||
| Jan G Hengstler | Q49800573 | ||
| P2093 | author name string | Arne Schenk | |
| Albert Braeuning | |||
| Michael Schwarz | |||
| Reham Hassan | |||
| P2860 | cites work | Biotransformation of pravastatin sodium in humans | Q68317456 |
| Species differences in metabolism of codeine: urinary excretion of codeine glucuronide, morphine-3-glucuronide and morphine-6-glucuronide in mice, rats, guinea pigs and rabbits | Q68600284 | ||
| Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse | Q70803074 | ||
| Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2 | Q71690593 | ||
| Identification of talinolol metabolites in urine of man, dog, rat and mouse after oral administration by high-performance liquid chromatography-thermospray tandem mass spectrometry | Q71961450 | ||
| Physiological parameters in laboratory animals and humans | Q72935917 | ||
| Spatio-temporal simulation of first pass drug perfusion in the liver | Q27322901 | ||
| A Microfabricated Platform for Generating Physiologically-Relevant Hepatocyte Zonation | Q28829727 | ||
| Using expression data for quantification of active processes in physiologically based pharmacokinetic modeling | Q34147024 | ||
| Clinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic events | Q34147623 | ||
| A concordance correlation coefficient to evaluate reproducibility | Q34527574 | ||
| Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model | Q35112180 | ||
| Metabolic zonation of the liver: regulation and implications for liver function | Q35417325 | ||
| Modelling and PBPK simulation in drug discovery | Q37413064 | ||
| Liver transporters in hepatic drug disposition: an update | Q37581643 | ||
| Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds | Q40100581 | ||
| Expression, purification, and characterization of mouse CYP2d22. | Q40295746 | ||
| Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease | Q40770241 | ||
| Model-guided identification of a therapeutic strategy to reduce hyperammonemia in liver diseases | Q40881866 | ||
| Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver | Q41333879 | ||
| Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model | Q41582110 | ||
| Clinical pharmacokinetics and pharmacodynamics of torasemide | Q41706099 | ||
| Pharmacokinetics of oral talinolol following a single dose and during steady state in patients with chronic renal failure and healthy volunteers | Q43555022 | ||
| Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2. | Q44058008 | ||
| Expression of the Human CYP3A4 Gene in the Small Intestine of Transgenic Mice: In Vitro Metabolism and Pharmacokinetics of Midazolam | Q44403612 | ||
| Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice. | Q45122051 | ||
| Integrated metabolic spatial-temporal model for the prediction of ammonia detoxification during liver damage and regeneration | Q46550945 | ||
| A systematic evaluation of the use of physiologically based pharmacokinetic modeling for cross-species extrapolation | Q46814759 | ||
| Characterization of 1'-hydroxymidazolam glucuronidation in human liver microsomes | Q46903207 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6224 | |
| P577 | publication date | 2017-07-24 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Physiologically-based modelling in mice suggests an aggravated loss of clearance capacity after toxic liver damage | |
| P478 | volume | 7 |
| Q49218533 | Highlight report: Monitoring cytochrome P450 activities in living hepatocytes |
| Q64947056 | Highlight report: Necrosis-apoptosis conundrum of hepatocytes: mode of hepatocyte death after acetaminophen intoxication. |
| Q64932520 | Highlight report: Protection of cholestatic livers by shunting of bile from canaliculi to sinusoids. |
| Q49185998 | Highlight report: The pseudolobule in liver fibrosis |
| Q49607107 | Highlight report: physiologically-based modeling of diseased liver tissue |
| Q64062092 | Influence Factors of the Pharmacokinetics of Herbal Resourced Compounds in Clinical Practice |
| Q91762627 | Influence of Liver Fibrosis on Lobular Zonation |
| Q92644459 | Liver fibrosis causes periportalization of lobular zonation |
| Q64979594 | Modeling the Dynamics of Human Liver Failure Post Liver Resection. |
| Q92644463 | TGR5 regulates portal perfusion pressure of the liver |
| Q58802345 | The antioxidant activities of alkalic-extractable polysaccharides from Coprinus comatus on alcohol-induced liver injury in mice |
Search more.